Published in Drug Alcohol Rev on September 01, 2010
The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction (2011) 1.73
Impact of perceived discrimination in healthcare on patient-provider communication. Med Care (2011) 1.20
Psychiatric comorbidity and perceived alcohol stigma in a nationally representative sample of individuals with DSM-5 alcohol use disorder. Alcohol Clin Exp Res (2014) 0.82
Barriers to the acceptance of work colleagues infected with Hepatitis B and Hepatitis C in Japan. J Occup Health (2016) 0.79
Preventable hospitalizations among adult Medicaid beneficiaries with concurrent substance use disorders. Prev Med Rep (2015) 0.77
Racial/Ethnic Differences in Recent Drug Detoxification Enrollment and the Role of Discrimination and Neighborhood Factors. Subst Use Misuse (2013) 0.76
Good Psychometric Properties of the Addiction Version of the Revised Illness Perception Questionnaire for Health Care Professionals. PLoS One (2016) 0.75
"Don't Judge a Book Its Cover": A Qualitative Study of Methadone Patients' Experiences of Stigma. Subst Abuse (2017) 0.75
Evaluation of an online injecting drug use stigma intervention targeted at health providers in New South Wales, Australia. Health Psychol Open (2017) 0.75
Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics. Drug Alcohol Rev (2005) 4.02
The gendered context of initiation to injecting drug use: evidence for women as active initiates. Drug Alcohol Rev (2007) 1.65
Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clin Infect Dis (2005) 1.36
Single index of multimorbidity did not predict multiple outcomes. J Clin Epidemiol (2005) 1.25
The social production of hepatitis C risk among injecting drug users: a qualitative synthesis. Addiction (2008) 1.24
How can hepatitis C be prevented in the long term? Int J Drug Policy (2007) 1.18
Rural general practitioner apprehension about work related violence in australia. Aust J Rural Health (2003) 1.15
Prisons, hepatitis C and harm minimisation. Med J Aust (2007) 1.14
Darwinian grandparenting: preferential investment in more certain kin. Pers Soc Psychol Bull (2005) 1.10
Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study. Clin Infect Dis (2013) 1.09
Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting. Drug Alcohol Depend (2009) 1.00
Some characteristics of early-onset injection drug users prior to and at the time of their first injection. Addiction (2006) 0.99
Resilient coping: applying adaptive responses to prior adversity during treatment for hepatitis C infection. J Health Psychol (2008) 0.97
Implicit prejudice toward injecting drug users predicts intentions to change jobs among drug and alcohol nurses. Psychol Sci (2008) 0.95
Equity of access to treatment, and barriers to treatment for illicit drug use in Australia. Addiction (2007) 0.94
Measuring attitudes toward injecting drug users and people with hepatitis C. Subst Use Misuse (2008) 0.93
Prejudice among health care workers toward injecting drug users with hepatitis C: does greater contact lead to less prejudice? Int J Drug Policy (2007) 0.92
Interacting with sexist men triggers social identity threat among female engineers. J Pers Soc Psychol (2009) 0.92
Age, race, and implicit prejudice: using process dissociation to separate the underlying components. Psychol Sci (2009) 0.92
Stereotype threat increases the likelihood that female drivers in a simulator run over jaywalkers. Accid Anal Prev (2007) 0.91
The experience of interferon-based treatments for hepatitis C infection. Qual Health Res (2005) 0.90
Stereotype threat contributes to social difficulties in people with schizophrenia. Br J Clin Psychol (2009) 0.90
Indigenous Australian medical students' perceptions of their medical school training. Med Educ (2009) 0.89
Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales. Drug Alcohol Rev (2006) 0.89
Stereotype Activation, Inhibition, and Aging. J Exp Soc Psychol (2010) 0.88
Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney. Drug Alcohol Rev (2010) 0.88
A functional polymorphism of the MAOA gene is associated with neural responses to induced anger control. J Cogn Neurosci (2014) 0.88
Addiction journal is committed to publishing qualitative research. Addiction (2013) 0.87
Under the watchful eye of 'a benevolent dictator' - general practitioner and patient experiences of hepatitis C treatment initiation and shared-care in general practice. Aust Fam Physician (2013) 0.87
Coping with stereotype threat: denial as an impression management strategy. J Pers Soc Psychol (2005) 0.87
Social inappropriateness, executive control, and aging. Psychol Aging (2009) 0.86
Initiators: an examination of young injecting drug users who initiate others to injecting. AIDS Behav (2007) 0.86
One size fits all? The discursive framing of cultural difference in health professional accounts of providing cancer care to Aboriginal people. Ethn Health (2013) 0.85
Age differences in neural activity during slot machine gambling: an fMRI study. PLoS One (2012) 0.84
Aging and stereotype suppression. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2008) 0.84
Chronic illness experiences, clinical markers and living with hepatitis C. J Health Psychol (2007) 0.83
Pleasure and drugs. Int J Drug Policy (2008) 0.82
Staying safe from hepatitis C: engaging with multiple priorities. Qual Health Res (2011) 0.82
Endogenous testosterone and cortisol modulate neural responses during induced anger control. Soc Neurosci (2012) 0.82
At the intersection of marginalised identities: lesbian, gay, bisexual and transgender people's experiences of injecting drug use and hepatitis C seroconversion. Health Soc Care Community (2013) 0.81
Using partially structured attitude measures to enhance the attitude-behavior relationship. Pers Soc Psychol Bull (2004) 0.81
Evaluation of an integrated care service facility for people living with hepatitis C in New Zealand. Int J Integr Care (2012) 0.81
Pretreatment preparation and management of interferon-based therapy for hepatitis C virus infection. J Adv Nurs (2007) 0.81
Harm minimisation in Australian prisons--health protection still depends on where you serve your time. Med J Aust (2012) 0.80
'Not just methadone Tracy': transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings. Addiction (2014) 0.79
Blood and bioidentity: ideas about self, boundaries and risk among blood donors and people living with hepatitis C. Soc Sci Med (2004) 0.79
Social behavior in mild cognitive impairment and early dementia. J Clin Exp Neuropsychol (2012) 0.79
Alexithymia in schizophrenia. J Clin Exp Neuropsychol (2010) 0.79
The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection. Int J Drug Policy (2007) 0.78
Improving surveillance for acute hepatitis C. Commun Dis Intell Q Rep (2011) 0.78
Health worker attitudes toward peer workers in hepatitis C prevention. Psychol Health Med (2012) 0.78
The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics. Soc Sci Med (2011) 0.78
Discrimination by health care workers versus discrimination by others: countervailing forces on HCV treatment intentions. Psychol Health Med (2014) 0.78
Exploring the role of consumer participation in drug treatment. Drug Alcohol Depend (2009) 0.77
Depression, Anxiety, and Stress Among People With Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia. J Addict Med (2016) 0.76
Disclosing hepatitis C infection within everyday contexts: implications for accessing support and healthcare. J Health Psychol (2010) 0.76
Preventing transitions to injecting amongst young people: what is the role of Needle and Syringe Programmes? Int J Drug Policy (2009) 0.76
Young people at risk of transitioning to injecting drug use in Sydney, Australia: social disadvantage and other correlates of higher levels of exposure to injecting. Health Soc Care Community (2014) 0.76
Knowledge and attitudes towards hepatitis C and injecting drug use among mental-health support workers of a community managed organisation. Aust Health Rev (2013) 0.75
'Towards a global approach'--an overview of Harm Reduction 2008: IHRA's 19th International Conference. Int J Drug Policy (2008) 0.75
Sexual regret: evidence for evolved sex differences. Arch Sex Behav (2012) 0.75
Applied communitarian ethics for harm reduction: promoting a dialogue within the field. Drug Alcohol Rev (2007) 0.75
Representations of people with HIV and hepatitis C in editorials of medical journals: discourses and interdiscursive relations. Commun Med (2006) 0.75
Implicit attitudes, emotions, and helping intentions of mental health workers toward their clients. J Nerv Ment Dis (2013) 0.75
Caffeine expectancies but not caffeine reduce depletion-induced aggression. Psychol Addict Behav (2011) 0.75
Assessing community support for harm reduction services: comparing two measures. Drug Alcohol Rev (2010) 0.75
Do Sitting, Standing or Treadmill Desks Impact Psychobiological Indicators of Work Productivity? J Phys Act Health (2017) 0.75
'Makes you wanna do treatment': benefits of a hepatitis C specialist clinic to clients in Christchurch, New Zealand. Health Soc Care Community (2012) 0.75
NSPs and the media: a case study of balanced and accurate reporting? Aust N Z J Public Health (2005) 0.75
The proof is in the toothpaste: police ordered exclusion as a result of research participation. Aust N Z J Public Health (2010) 0.75
"I Had a Little Bit of a Bloke Meltdown…But the Next Day, I Was Up": Understanding Cancer Experiences Among Aboriginal Men. Cancer Nurs (2016) 0.75